ATTRACTIVE COLOPLAST IS STILL UNATTRACTIVELY PRICED (REDUCE; 1.5% DOWNSIDE)
07/05/21 -" Coloplast (Reduce, Denmark) is, fundamentally, an attractive business (AV fundamental strength score of 9/10 vs 7.7 for AV MedTech and 5.4 for AV universe). The sector-leading return metrics tell a ..."
Pages
64
Language
English
Published on
07/05/21
You may also be interested by these reports :
10/07/26
Following Thermo Fisher’s unsuccessful bid in 2020, Qiagen gradually restructured its business, focusing on non-COVID growth avenues. However, in ...
10/07/26
Non Pharma Health stocks have long been suffering. The sector has lost 39% ytd, not helped by EssilorLuxottica’s -35% correction. EL’s connected ...
23/06/26
There’s an interesting paradox at the heart of Sartorius Stedim Biotech’s (SSB; ADD; France) investment case. Since our last push in February 2025, ...
03/06/26
Despite a reduction in our target price, as discussed in the EPS section, our positive recommendation on Qiagen remains unchanged. This optimism is ...